These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 38937523)
1. Production of norovirus-, rotavirus-, and enterovirus-like particles in insect cells is simplified by plasmid-based expression. Lampinen V; Gröhn S; Lehmler N; Jartti M; Hytönen VP; Schubert M; Hankaniemi MM Sci Rep; 2024 Jun; 14(1):14874. PubMed ID: 38937523 [TBL] [Abstract][Full Text] [Related]
2. A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice. Wang X; Ku Z; Dai W; Chen T; Ye X; Zhang C; Zhang Y; Liu Q; Jin X; Huang Z Vaccine; 2015 Oct; 33(43):5779-5785. PubMed ID: 26424606 [TBL] [Abstract][Full Text] [Related]
3. Production of Virus-Like Particles for Vaccination. Thompson CM; Aucoin MG; Kamen AA Methods Mol Biol; 2016; 1350():299-315. PubMed ID: 26820864 [TBL] [Abstract][Full Text] [Related]
4. Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells. Somasundaram B; Chang C; Fan YY; Lim PY; Cardosa J; Lua L Methods; 2016 Feb; 95():38-45. PubMed ID: 26410190 [TBL] [Abstract][Full Text] [Related]
5. Application of advanced quantification techniques in nanoparticle-based vaccine development with the Sf9 cell baculovirus expression system. Puente-Massaguer E; Lecina M; Gòdia F Vaccine; 2020 Feb; 38(7):1849-1859. PubMed ID: 31911032 [TBL] [Abstract][Full Text] [Related]
6. Improved Production Efficiency of Virus-Like Particles by the Baculovirus Expression Vector System. López-Vidal J; Gómez-Sebastián S; Bárcena J; Nuñez Mdel C; Martínez-Alonso D; Dudognon B; Guijarro E; Escribano JM PLoS One; 2015; 10(10):e0140039. PubMed ID: 26458221 [TBL] [Abstract][Full Text] [Related]
7. Chimaeric virus-like particles derived from consensus genome sequences of human rotavirus strains co-circulating in Africa. Jere KC; O'Neill HG; Potgieter AC; van Dijk AA PLoS One; 2014; 9(9):e105167. PubMed ID: 25268783 [TBL] [Abstract][Full Text] [Related]
8. Production and Application of Insect Virus-Based VLPs. Gopal R; Schneemann A Methods Mol Biol; 2018; 1776():125-141. PubMed ID: 29869238 [TBL] [Abstract][Full Text] [Related]
9. Identification of Essential Genetic Baculoviral Elements for Recombinant Protein Expression by Transactivation in Sf21 Insect Cells. Bleckmann M; Schürig M; Chen FF; Yen ZZ; Lindemann N; Meyer S; Spehr J; van den Heuvel J PLoS One; 2016; 11(3):e0149424. PubMed ID: 26934632 [TBL] [Abstract][Full Text] [Related]
11. Efficient expression of enterovirus 71 based on virus-like particles vaccine. Kim HJ; Son HS; Lee SW; Yoon Y; Hyeon JY; Chung GT; Lee JW; Yoo JS PLoS One; 2019; 14(3):e0210477. PubMed ID: 30845175 [TBL] [Abstract][Full Text] [Related]
12. Development of a non-viral platform for rapid virus-like particle production in Sf9 cells. Puente-Massaguer E; Gòdia F; Lecina M J Biotechnol; 2020 Oct; 322():43-53. PubMed ID: 32673687 [TBL] [Abstract][Full Text] [Related]
13. Enhanced enterovirus 71 virus-like particle yield from a new baculovirus design. Lin SY; Yeh CT; Li WH; Yu CP; Lin WC; Yang JY; Wu HL; Hu YC Biotechnol Bioeng; 2015 Oct; 112(10):2005-15. PubMed ID: 25997678 [TBL] [Abstract][Full Text] [Related]
14. Modular vaccine platform based on the norovirus-like particle. Lampinen V; Heinimäki S; Laitinen OH; Pesu M; Hankaniemi MM; Blazevic V; Hytönen VP J Nanobiotechnology; 2021 Jan; 19(1):25. PubMed ID: 33468139 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates. Lim PY; Hickey AC; Jamiluddin MF; Hamid S; Kramer J; Santos R; Bossart KN; Cardosa MJ Vaccine; 2015 Nov; 33(44):6017-24. PubMed ID: 26271825 [TBL] [Abstract][Full Text] [Related]
16. Integrating nanoparticle quantification and statistical design of experiments for efficient HIV-1 virus-like particle production in High Five cells. Puente-Massaguer E; Lecina M; Gòdia F Appl Microbiol Biotechnol; 2020 Feb; 104(4):1569-1582. PubMed ID: 31907573 [TBL] [Abstract][Full Text] [Related]
17. Production of rotavirus core-like particles in Sf9 cells using recombinase-mediated cassette exchange. Fernandes F; Dias MM; Vidigal J; Sousa MF; Patrone M; Teixeira AP; Alves PM J Biotechnol; 2014 Feb; 171():34-8. PubMed ID: 24333128 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Bertolotti-Ciarlet A; Ciarlet M; Crawford SE; Conner ME; Estes MK Vaccine; 2003 Sep; 21(25-26):3885-900. PubMed ID: 12922123 [TBL] [Abstract][Full Text] [Related]
19. Virus-like particle and viral vector production using the baculovirus expression vector system/insect cell system: adeno-associated virus-based products. Aucoin MG; Jacob D; Chahal PS; Meghrous J; Bernier A; Kamen AA Methods Mol Biol; 2007; 388():281-96. PubMed ID: 17951776 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of rotavirus-like particles in insect cells: comparative and quantitative analysis. Jiang B; Barniak V; Smith RP; Sharma R; Corsaro B; Hu B; Madore HP Biotechnol Bioeng; 1998 Nov; 60(3):369-74. PubMed ID: 10099441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]